May 30, 2007 -
OptiChallenge Inhibition Panel allows laboratories and manufacturers to identify testing limitations and take appropriate actions while evaluating performance of assay in presence of interfering substances. This 7-member panel provides quantified amounts of commonly recognized and accepted inhibitors and can be used in various ways, including assay validation, instrument evaluation, commercial and in-house assay characterization, and troubleshooting.
Archive Press Release
(Products mentioned in this Archive Press Release may or may not be available from the manufacturer.)
Release date: May 2, 2007
AcroMetrix Announces Launch of OptiChallenge Inhibition Panel
BENICIA, Calif., May 2 -- AcroMetrix announced today at the Clinical Virology meeting in Clearwater Florida the launch of the OptiChallenge Inhibition Panel for use in evaluating the performance of an assay in the presence of interfering substances. The seven member panel is the first to provide quantified amounts of commonly recognized and accepted inhibitors. The panel members represent elevated levels of inhibitory substances that can be routinely encountered in the normal patient population.
Interfering substances such as heparin, lipids, bilirubin, and haemolyzed plasma are commonly found in patient samples. At minimal levels, these substances do not obstruct assay results. However, when levels become elevated due to lifestyle or medications, these substances can hinder the amplification of the nucleic acid assays and retard the data reported. U. S studies show that 12.5% of incorrect and delayed test results affect patient health. OptiChallenge Inhibition Panel allows laboratories to identify a testing limitation and take appropriate actions.
"The OptiChallenge Inhibition Panel is a novel new product for a laboratory or manufacturer looking to establish and evaluate the performance of their assay or sample preparation method in the presence of interfering substances," said Matt Trappe, Global Product Manager, "OptiChallenge IP's time savings and flexibility-of-use will be invaluable to the laboratory on its quest to increase quality."
The OptiChallenge Inhibition Panel can be used in a variety of ways, including assay validation, instrument evaluation, commercial and in-house assay characterization, and troubleshooting. This product is for research use only, intended for use when validating FDA approved, modified and in-house assays; troubleshooting problems and setting acceptance standards. The product's consistent and quantified levels of interfering substances provide the laboratory the first external standard for interference characterization.
About AcroMetrix - AcroMetrix, with facilities in Benicia, California and Alkmaar, The Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. For more information on AcroMetrix please visit the company web site at www.acrometrix.com.
CONTACT: Audrey Hughey, +1-707-746-8888 ext. 123, or +1-707-746-8881, or arh@acrometrix.com
Contacts:
General Information:
Audrey Hughey
USA
Phone: 707-746-8888 ext 123 E-mail this person Company Information: Name: AcroMetrix Address: 6058 Egret Court City: Benicia State: CA ZIP: 94510 Country: USA Phone: 888-746-7921 FAX: 707-746-8881 http://www.acrometrix.com
News provided by ThomasNet Industrial Newsroom® (TIN). TIN is a comprehensive source
of new and timely product information in the industrial marketplace. TIN supplies new product
information to the web sites, e-marketplaces and print publications that serve the
industrial marketplace. For press release submissions please go to
http://www.productnews.com/SubmitPRPage.html.
BY ACCESSING, BROWSING AND/OR USING THIS WEB SITE AND/OR ANY WEB SITES PROVIDED BY
ProductNews.com, YOU AGREE TO BE BOUND BY THE TERMS OF USE
AGREEMENT.
![[Get Copyright Permissions]](http://license.icopyright.net/images/icopy-w.gif){kind=small}
